Evidence map›Paper›PMID 38504107›Full record

ArticleNature communications2024

Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer.

Guoshu Bi, Jiaqi Liang, Yunyi Bian, Guangyao Shan, Yiwei Huang, Tao Lu, Huan Zhang, Xing Jin, Zhencong Chen, Mengnan Zhao and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Guoshu Bi *Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Jiaqi Liang *Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yunyi Bian *Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Guangyao ShanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yiwei HuangDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Tao LuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Huan ZhangDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Xing JinDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhencong ChenDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Mengnan ZhaoDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Hong FanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Qun WangDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0003-4853-1727
Boyi GanDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bgan@mdanderson.org.ORCID http://orcid.org/0000-0001-8884-6040
Cheng ZhanDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. czhan10@fudan.edu.cn.ORCID http://orcid.org/0000-0001-8745-9276
Sun Yat-sen University · CNThe University of Texas MD Anderson Cancer Center · US

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82103311Natural Science Foundation of Shanghai (Natural Science Foundation of Shanghai Municipality) 22ZR1411900
6 · The paper itself

Abstract

Targeting ferroptosis, an iron-dependent form of regulated cell death triggered by the lethal overload of lipid peroxides, in cancer therapy is impeded by our limited understanding of the intersection of tumour's metabolic feature and ferroptosis vulnerability. In the present study, arginine is identified as a ferroptotic promoter using a metabolites library. This effect is mainly achieved through arginine's conversion to polyamines, which exerts their potent ferroptosis-promoting property in an H

Indexed as

FerroptosisIron OverloadNeoplasmsArginineCell Line, TumorHumansHydrogen PeroxidePolyaminesArginineHydrogen PeroxidePolyamines

Identifiers

PMID38504107
PMCPMC10951362
OpenAlexW4392951752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.